Markets at a Glance: Pharmaceuticals

Report Highlights

The “Market at a Glance Pharmaceuticals” provides an access to all the market share analysis segments of the best-selling and key pharmaceutical reports of BCC Research. This report is a destination for the competitive landscape in the markets that hold a significant stand in the pharmaceuticals sector. Company profiles for all the notable manufacturers in the global pharmaceutical industry are provided as a part of this report.

Report Includes

• Examination of trends revolutionizing the pharmaceuticals sector
• An overview of Active Pharmaceutical Ingredients (API), antipsychotic drugs, and neuroprotective agents
• Information on Alnylam’s RNAi drug Onpattro, used to treat nerve damage from hereditary transthyretin-mediated amyloidosis
• Details pertaining to market share and company profiles of leading players of the industry

Report Scope

The “Market at a Glance Pharmaceuticals” provides a sampling of the market share in key therapeutics of pharmaceutical industry that has been aiding business decision making since the inception of BCC Research in 1971. It includes the market share and company profiles of leading players on the following markets:

• Active Pharmaceutical Ingredients: Global Markets to 2022 (PHM200A).
• Antipsychotic Drugs: Technologies and Global Markets (PHM063B).
• Brain Tumor Therapeutics: Global Markets to 2023 (PHM208A).
• Clinical Nutrition: Global Markets to 2022 (PHM198A).
• Diagnostics and Therapeutics for HIV: Global Markets (PHM058C).
• Global Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic Divisions (PHM177B).
• The Global Influenza Market (PHM049E).
• Global Markets for Treatment and Diagnosis of Sexually Transmitted Diseases (PHM005D).
• Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging (PHM043G).
• Global Markets for Infectious Disease Treatments (PHM061D).
• Neuroprotective Agents: Therapeutic Applications and Global Markets (PHM188A).

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

• Bioprocess Optimization and Digital Bio-manufacturing: Global Markets (BIO170B)
• Metal-organic Frameworks: Global Markets (AVM200B)
• Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets (PHM204C)
• Global DNA Sequencing: Research, Applied and Clinical Markets (BIO045J)
• Surgical Equipment: Technologies and Global Markets (HLC154C)